EPRX.TO
Eupraxia Pharmaceuticals Inc
Price:  
4.64 
CAD
Volume:  
2,000.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EPRX.TO WACC - Weighted Average Cost of Capital

The WACC of Eupraxia Pharmaceuticals Inc (EPRX.TO) is 5.1%.

The Cost of Equity of Eupraxia Pharmaceuticals Inc (EPRX.TO) is 5.20%.
The Cost of Debt of Eupraxia Pharmaceuticals Inc (EPRX.TO) is 5.00%.

Range Selected
Cost of equity 4.60% - 5.80% 5.20%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.5% - 5.7% 5.1%
WACC

EPRX.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.27 0.27
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.60% 5.80%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.07 0.07
Cost of debt 5.00% 5.00%
After-tax WACC 4.5% 5.7%
Selected WACC 5.1%